Perel Pablo, Roberts Ian
Cochrane Injuries Group, London School of Hygiene & Tropical Medicine, London, UK.
Cochrane Database Syst Rev. 2012 Jun 13(6):CD000567. doi: 10.1002/14651858.CD000567.pub5.
Colloid solutions are widely used in fluid resuscitation of critically ill patients. There are several choices of colloid and there is ongoing debate about the relative effectiveness of colloids compared to crystalloid fluids.
To assess the effects of colloids compared to crystalloids for fluid resuscitation in critically ill patients.
We searched the Cochrane Injuries Group Specialised Register (searched 16 March 2012), Cochrane Central Register of Controlled Trials 2011, issue 3 (The Cochrane Library), MEDLINE (Ovid) 1946 to March 2012, Embase (Ovid) 1980 to March 2012, ISI Web of Science: Science Citation Index Expanded (1970 to March 2012), ISI Web of Science: Conference Proceedings Citation Index-Science (1990 to March 2012), PubMed (searched 16 March 2012), www.clinical trials.gov and www.controlled-trials.com. We also searched the bibliographies of relevant studies and review articles.
Randomised controlled trials (RCTs) of colloids compared to crystalloids, in patients requiring volume replacement. We excluded cross-over trials and trials in pregnant women and neonates.
Two authors independently extracted data and rated quality of allocation concealment. We analysed trials with a 'double-intervention', such as those comparing colloid in hypertonic crystalloid to isotonic crystalloid, separately. We stratified the analysis according to colloid type and quality of allocation concealment.
We identified 74 eligible trials; 66 of these presented mortality data.Colloids compared to crystalloids Albumin or plasma protein fraction - 24 trials reported data on mortality, including a total of 9920 patients. The pooled relative risk (RR) from these trials was 1.01 (95% confidence interval (CI) 0.93 to 1.10). When we excluded the trial with poor quality allocation concealment, pooled RR was 1.00 (95% CI 0.92 to 1.09). Hydroxyethyl starch - 21 trials compared hydroxyethyl starch with crystalloids, n = 1385 patients. The pooled RR was 1.10 (95% CI 0.91 to 1.32). Modified gelatin - 11 trials compared modified gelatin with crystalloid, n = 506 patients. The pooled RR was 0.91 (95% CI 0.49 to 1.72). (When the trials by Boldt et al were removed from the three preceding analyses, the results were unchanged.) Dextran - nine trials compared dextran with a crystalloid, n = 834 patients. The pooled RR was 1.24 (95% CI 0.94 to 1.65).Colloids in hypertonic crystalloid compared to isotonic crystalloid Nine trials compared dextran in hypertonic crystalloid with isotonic crystalloid, including 1985 randomised participants. Pooled RR was 0.91 (95% CI 0.71 to 1.06).
AUTHORS' CONCLUSIONS: There is no evidence from RCTs that resuscitation with colloids reduces the risk of death, compared to resuscitation with crystalloids, in patients with trauma, burns or following surgery. As colloids are not associated with an improvement in survival, and as they are more expensive than crystalloids, it is hard to see how their continued use in these patients can be justified outside the context of RCTs.
胶体溶液广泛用于危重症患者的液体复苏。胶体有多种选择,关于胶体与晶体液相比的相对有效性一直存在争议。
评估胶体与晶体液相比在危重症患者液体复苏中的效果。
我们检索了Cochrane损伤组专业注册库(检索时间为2012年3月16日)、2011年第3期Cochrane对照试验中央注册库(Cochrane图书馆)、1946年至2012年3月的MEDLINE(Ovid)、1980年至2012年3月的Embase(Ovid)、ISI科学网:科学引文索引扩展版(1970年至2012年3月)、ISI科学网:会议论文引文索引 - 科学版(1990年至2012年3月)、PubMed(检索时间为2012年3月16日)、www.clinicaltrials.gov和www.controlled-trials.com。我们还检索了相关研究和综述文章的参考文献。
胶体与晶体液比较的随机对照试验(RCT),纳入需要容量补充的患者。我们排除了交叉试验以及孕妇和新生儿的试验。
两位作者独立提取数据并对分配隐藏的质量进行评分。我们对具有“双重干预”的试验进行单独分析,例如那些将高渗晶体液中的胶体与等渗晶体液进行比较的试验。我们根据胶体类型和分配隐藏质量对分析进行分层。
我们确定了74项符合条件的试验;其中66项呈现了死亡率数据。
胶体与晶体液比较
白蛋白或血浆蛋白组分 - 24项试验报告了死亡率数据,共纳入9920例患者。这些试验汇总的相对风险(RR)为1.01(95%置信区间(CI)0.93至1.10)。当我们排除分配隐藏质量差的试验后,汇总RR为1.00(95%CI 0.92至1.09)。
羟乙基淀粉 - 21项试验将羟乙基淀粉与晶体液进行比较,n = 1385例患者。汇总RR为1.10(95%CI 0.91至1.32)。
改良明胶 - 11项试验将改良明胶与晶体液进行比较,n = 506例患者。汇总RR为0.91(95%CI 0.49至1.72)。(从前三项分析中剔除Boldt等人的试验后,结果不变。)
右旋糖酐 - 9项试验将右旋糖酐与晶体液进行比较,n = 834例患者。汇总RR为1.24(95%CI 0.94至1.65)。
高渗晶体液中的胶体与等渗晶体液比较
9项试验将高渗晶体液中的右旋糖酐与等渗晶体液进行比较,包括1985名随机参与者。汇总RR为0.91(95%CI 0.71至1.06)。
随机对照试验没有证据表明,与晶体液复苏相比,胶体复苏能降低创伤、烧伤或手术后患者的死亡风险。由于胶体不能改善生存率,且比晶体液更昂贵,所以很难理解在随机对照试验之外继续在这些患者中使用胶体的合理性。